CAR-T & Cellular Therapy
CAR-T in the CLL space
Novel combinations work well for many patients suffering from chronic lymphocytic leukemia (CLL), but there is a subset of patients…
Date: 2nd April 2020
CAR T-cell therapy & multiple myeloma: past, present & future
CAR-T cell therapy offers a potentially paradigm-changing new treatment for multiple myeloma. Additionally, CAR-T toxicity is may be more manageable…
Date: 2nd April 2020
Induction therapy in myeloma: an ever-changing paradigm
In the majority of hematologic malignancies, induction treatment is given to achieve complete remission. In multiple myeloma, this has only…
Date: 18th July 2019
iwAL 2019: looking to the future of acute leukemia therapy
The treatment landscape of acute myeloid and lymphoblastic leukemia continues to evolve with the addition of novel therapies and methods…
Date: 6th June 2019
Acute leukemia: pushing boundaries in disease management
This is an exciting time in the acute leukemia field, with advances in both the treatment landscape and the pathology…
Date: 6th June 2019
CAR T-cell therapy and precision medicine in non-Hodgkin lymphoma
Precision medicine provides an array of benefits for the treatment of non-Hodgkin lymphoma patients, but it also has its challenges….
Date: 18th December 2018
CAR T-cells in myeloma: exploratory targets, payment models & treatment sequence
CAR T-cell therapy presents the opportunity to completely revolutionize the treatment of multiple myeloma, with research currently exploring the optimal…
Date: 11th October 2018
Patient discussion at EHA 2018: CAR T-cells and MRD in CLL
CAR T-cells have demonstrated impressive efficacy in a variety of hematological malignancies, but their use in chronic lymphocytic leukemia (CLL)…
Date: 14th September 2018
CLL therapies today: novel agents, combinations & the future of the field
Chronic lymphocytic leukemia (CLL) is experiencing a revolution in its treatment approaches. New therapies are constantly in development, and the…
Date: 20th August 2018
CAR T-cell therapy: where are we now and what’s in store for the future?
Over the last several years, CAR T-cell therapy has emerged as a revolution in immunotherapy, with incredible results to date….
Date: 25th July 2018
Revolutionary immunotherapies for lymphoma
Immunotherapy has emerged in recent years as an effective novel treatment for lymphoma, with studies constantly striving to identify new…
Date: 2nd February 2018
Latest advances and current challenges in immunotherapies for lymphoma
In this lively discussion, Catherine Bollard, MBChB, MD, FRACP, FRCPA, from the Children’s National Health System and George Washington University,…
Date: 15th December 2017
